Objectives of Programme's Learning Outcomes

• 1. Pharmaceutical expertise: Use a foundation of concepts and knowledge in health sciences and pharmaceutical sciences.
• Understand and integrate the fundamental sciences (chemistry, physics, biology, botany) involved in the specific fields of pharmaceutical sciences
• Understand how the human body works by using knowledge of anatomy, biochemistry, physiology, immunology, microbiology and pathology under the dual approach of normal and pathological conditions in order to understand the action of medications on the body.
• Understand the basic concepts of pharmacology and pharmacokinetics
• Understand compounds for pharmaceutical application regarding their chemical structures, their structure-activity relationships, their physicochemical properties, their origins (synthetic, semi-synthetic, natural), their analytical control methods and their areas of use from a therapeutic point of view.
• 2. Scientific method: Solve pharmaceutical problems using their knowledge and critical mind.
• Understand and apply the basic principles of reasoning (obtaining data, analysis, synthesis, comparison, the rule of three, syllogism, analogy, Boolean logic, etc.)
• Use a hypothesis in inductive, deductive or abductive reasoning
• Develop a critical, practical and analytical mind
• 3. Communication: Communicate in an appropriate, efficient, rigorous and respectful way in a professional perspective.
• Understand the basic rules of French and of English (grammar, punctuation, connectors, etc.).
• Adapt lexical and syntactic choices in communication register (everyday language, medical language or scientific terminology)
• Summarise, explain, and argue
• Share knowledge and information
• 4. Sense of responsibility: Act ethically and professionally.
• Be aware of the concept of "pharmaceutical care"
• 5. Quality: Assess themself, expand their knowledge and adapt their attitude.
• Manage time
• Prioritise
• Locate scientific information efficiently

Learning Outcomes of UE

The student must be able to learn several aspects of the drugs used in Belgium, among which their pharmacological and physico-chemical properties, their pratical uses in medicine, how to analyse them and how to create new drugs.

Content of UE

* Theory: analysis of chemical groups; drug design at the molecular level (molecular pharmacochemistry); systematic study of several pharmaceutical classes (anti-infectious drugs, antitumoral and immunomodulatory drugs; peripheral nervous system drugs). * Laboratory work: analysis of several samples of drugs (with our without impurities) following a European Pharmacopoeia monograph (identity, purity and assay).

Prior Experience

Prerequisites : Chimie organique. Pharmacologie générale.   Courses to be followed along with the present UE : Chimie analytique qualitative et quantitative Analyse instrumentale pharmaceutique Etude des médicaments inorganiques Pharmacognosie: Phytochimie et étude des médicaments d'origine végétale Pharmacologie générale

Type of Assessment for UE in Q1

• Written examination
• Practical test
• Quoted exercices

Q1 UE Assessment Comments

Final mark : 2/3 for the theoretical examination and 1/3 for the practical work (within this last section : the mean of the practical work contributes for 2/3 of the final mark and the practical work written examination for 1/3). However, if the theoretical examination is not successful (score strictly less than 10/20), only the theoretical mark is taken into account. <b>Warnings regarding the written examination</b>: Each question is scored on 0.5, 1 or 2 depending on the expected level of response. The intermediate mark is calculated from the total marks for the entire examination and then recalculated to 20 for the final mark. Depending on the quality of <b>incorrect response given</b> (eg, errors considered serious in terms of the importance of the covered concepts or their fundamental aspect regarding the level of study) or the <b>quality of expression answers</b> (eg, globaly for the examination: poorly organized answers, not correctly written, or nebulous meaning), <b>additional points may be withdrawn without exceeding 2 on the final mark.</b> <b>Attendance at practical work sessions determines participation to the main final examination (theory). The student must attend at least 75% of the practical sessions and seminars. ANY absence must be justified. </b>

Type of Assessment for UE in Q3

• Written examination
• Quoted exercices

Q3 UE Assessment Comments

- There is no practical examination in Q3 but a possibility to present once again the theoretical examination related to practical work. - Final mark : 2/3 for the theoretical examination and 1/3 for the practical work (within this last section : the mean of the practical work contributes for 2/3 of the final mark and the practical work written examination for 1/3). However, if the theoretical examination is not successful (score strictly less than 10/20), only the theoretical mark is taken into account. <b>Warnings regarding the written examination</b>: - Each question is scored on 0.5, 1 or 2 depending on the expected level of response. The intermediate mark is calculated from the total marks for the entire examination and then recalculated to 20 for the final mark. - depending on the quality of <b>incorrect response given</b> (eg, errors considered serious in terms of the importance of the covered concepts or their fundamental aspect regarding the level of study) or the <b>quality of expression answers</b> (eg, globaly for the examination: poorly organized answers, not correctly written, or nebulous meaning), <b>additional points may be withdrawn without exceeding 2 on the final mark.</b> <b>Attendance at practical work sessions determines participation to the main final examination (theory). The student must attend at least 75% of the practical sessions and seminars. ANY absence must be justified. </b>

Type of Resit Assessment for UE in Q1 (BAB1)

• N/A

Q1 UE Resit Assessment Comments (BAB1)

Not applicable